Prior medical conditions and medication use and risk of non-Hodgkin lymphoma in Connecticut United States women
about
Autoimmune/Inflammatory Arthritis Associated Lymphomas: Who Is at Risk?Atopic dermatitis-like disease and associated lethal myeloproliferative disorder arise from loss of Notch signaling in the murine skinAssociations of non-Hodgkin Lymphoma (NHL) risk with autoimmune conditions according to putative NHL lociCurrent understanding of lifestyle and environmental factors and risk of non-hodgkin lymphoma: an epidemiological updateAnkylosing spondylitis, psoriatic arthritis, and risk of malignant lymphoma: a cohort study based on nationwide prospectively recorded data from Sweden.Aspirin and risk of multiple myeloma in adults: A systematic review and meta-analysis.Malignant lymphomas and autoimmunity-a single center experience from Hungary.Allergic conditions are not associated with the risk of non-Hodgkin's lymphoma or Hodgkin's lymphoma: a systematic review and meta-analysisEnvironmental risk factors in multiple sclerosis.Medical history, lifestyle, family history, and occupational risk factors for follicular lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.Genetic variation in N-acetyltransferases 1 and 2, cigarette smoking, and risk of non-Hodgkin lymphomaAlcohol consumption over time and risk of lymphoid malignancies in the California Teachers Study cohort.Do steroids increase lymphoma risk? A case-control study of lymphoma risk in polymyalgia rheumatica/giant cell arteritis.A novel two-stage, transdisciplinary study identifies digoxin as a possible drug for prostate cancer treatment.Statins use and the risk of all and subtype hematological malignancies: a meta-analysis of observational studiesPolymorphisms in Th1/Th2 cytokine genes, hormone replacement therapy, and risk of non-Hodgkin lymphoma.Oral contraceptives, menopausal hormone therapy use and risk of B-cell non-Hodgkin lymphoma in the California Teachers Study.Polymorphisms in immune function genes and non-Hodgkin lymphoma survival.Parity, Age at First Birth, and Risk of Death from Non-Hodgkin's Lymphoma: A Population-Based Cohort Study in TaiwanUse of statins and risk of haematological malignancies: a meta-analysis of six randomized clinical trials and eight observational studies.Self-reported history of infections and the risk of non-Hodgkin lymphoma: an InterLymph pooled analysis.Statins are associated with a reduced risk of cholangiocarcinoma: a population-based case-control study.Continuation with statin therapy and the risk of primary cancer: a population-based study.Epidemiology and etiology of non-Hodgkin lymphoma--a review.Hormonal and Reproductive Factors and Risk of Myeloproliferative Neoplasms in Postmenopausal Women.Statin use and cancer risk: an epidemiologic review.Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph ConsortiumPostmenopausal hormone therapy and non-Hodgkin lymphoma: a pooled analysis of InterLymph case-control studiesCigarette smoking and risk of non-Hodgkin lymphoma subtypes among womenImmune surveillance and lymphoid malignancy in immunocompromised host.Safety of topical calcineurin inhibitors for the treatment of atopic dermatitis.Topical calcineurin inhibitors and lymphoma risk: evidence update with implications for daily practice.National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening.CXCR5 polymorphisms in non-Hodgkin lymphoma risk and prognosis.The role of non-steroidal anti-inflammatory drugs in the risk of development and treatment of hematologic malignancies.Population-based study of autoimmune conditions and the risk of specific lymphoid malignanciesReproductive factors, exogenous hormone use and risk of lymphoid neoplasms among women in the National Institutes of Health-AARP Diet and Health Study Cohort.Non-Hodgkin lymphoma in women: reproductive factors and exogenous hormone useCommon immune-related risk factors and incident non-Hodgkin lymphoma: the multiethnic cohort.HMG-CoA reductase inhibitors (statins) use and risk of non-Hodgkin lymphoma in HIV-positive persons.
P2860
Q26739361-80D9536D-54DD-427E-B583-4381B3199659Q27334347-DC01677D-41D9-46E5-B3BD-EFCF482C5457Q28083556-4BA54604-BA8E-4113-9CA3-D63DB0F45BF1Q28388876-CB693367-DA8A-4441-BE95-FB535CDB6387Q30811500-007627F8-D06D-4862-AA03-CDF1FB44E73CQ30841754-BE5BC0C9-5EBB-4CFF-AEEE-9FFF809AF7A4Q33396131-A22ADC50-CDC7-41A5-891D-F722F88D6BA4Q33596923-687BB59F-7FCB-48AB-9C61-945B0B796BA3Q34100847-FB6DF977-1337-4ECD-983A-E08A5E1A683DQ34137923-78E78B20-0C26-4E8E-B95D-54FB14ACE358Q34273265-E3F3C02B-01DF-4395-8DF0-A92C8AC3202AQ35017460-60861729-369B-425D-8F83-D005320C38A1Q35555044-B3BADDB2-5500-4463-9B3C-40F438D5E01BQ35581883-7EA7ABD0-0976-402A-91F9-A8E6DF147629Q35602162-9ED9ECF0-5B98-434E-AF57-198341BBC322Q35612594-8E3060F5-D2DC-474A-B3D2-B75522BE360CQ35673920-B4814CA6-9D6D-40DF-AEBA-3573E4D66426Q35889753-45405541-F7CA-4774-AA09-13E8405052A1Q36012827-FA96D54F-E6B4-474F-A548-D44C8BBDFD57Q36024705-EF84009E-83BC-4F67-8CD1-BD958519D8F6Q36120539-7BB8B49A-1A82-4BEB-B5AF-1044957731B0Q36125495-27C78328-F3A1-4AA4-9820-C398A51664C0Q36330625-3B53695A-8584-47C5-959B-89FB9A0175D4Q36462529-25986F0D-E8C1-4490-9291-A82239629296Q36463786-E40CDBD6-596E-4041-9DB2-5F6B2A8BA1B7Q36508082-2A5D9AEF-D65C-4C2E-AD50-CB788B90CBC0Q36528740-C723E2D1-BFD7-4278-9184-40D24FCF667EQ36551642-C96F135C-AFB1-4C87-A967-45FBCFB64237Q36648098-FDD9E098-E21D-462E-BC3F-32CBF11963D2Q36831205-9D5CAA49-6C16-4EC1-83C1-AA0A5CCAFF07Q36861654-438360DD-0771-46D0-9AD2-ED09B211A16DQ36892767-B1E86DC8-73AC-4221-990E-85229D4D41B9Q37027264-80D29B1C-72F7-4412-91B1-F3AF86261327Q37135341-83593710-36CC-4B8D-80BC-D7DCB6164CBEQ37209932-21E0FC53-3415-4448-BE89-67A4C8D4D5B5Q37218079-7E23284B-6F05-4727-9180-4AECBB9F47FCQ37239336-F28C53F4-C3D2-4458-B589-4A8FECE57358Q37306222-2ED4BEEE-AEE3-4884-AC92-DCBF5EB9D73AQ37325965-015BD423-ABC8-4335-90E1-F551D96860DFQ37355991-A4AA1732-ABFD-4866-966F-9D30C5187406
P2860
Prior medical conditions and medication use and risk of non-Hodgkin lymphoma in Connecticut United States women
description
2004 nî lūn-bûn
@nan
2004 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Prior medical conditions and m ...... onnecticut United States women
@ast
Prior medical conditions and m ...... onnecticut United States women
@en
Prior medical conditions and m ...... onnecticut United States women
@nl
type
label
Prior medical conditions and m ...... onnecticut United States women
@ast
Prior medical conditions and m ...... onnecticut United States women
@en
Prior medical conditions and m ...... onnecticut United States women
@nl
prefLabel
Prior medical conditions and m ...... onnecticut United States women
@ast
Prior medical conditions and m ...... onnecticut United States women
@en
Prior medical conditions and m ...... onnecticut United States women
@nl
P2093
P50
P3181
P1476
Prior medical conditions and m ...... onnecticut United States women
@en
P2093
Bing Zhang
Brian Leaderer
Kaiyong Zou
Lindsay McOmber Morton
Patricia H Owens
Shelia Hoar Zahm
Stuart Flynn
Tongzhang Zheng
Yawei Zhang
P304
P3181
P356
10.1023/B:CACO.0000027506.55846.5D
P407
P577
2004-05-01T00:00:00Z
P6179
1019567995